[1]
“Real word effectiveness of benralizumab in mexican patients with severe eosinophilic asthma: Responders and super-responders”, Rev Alerg Mex, vol. 73, no. 1, pp. 17–25, Mar. 2026, doi: 10.29262/ram.v73i1.1562.